Table 4.

fT₄ and TSH concentrations of the OT+/OT– and UT+/UT- groups in age periods 1–3, 3–6, and 6–24 months

Age period, months	Treatment groups	Patients,n	Samples,n	fT4,pmol/L	p*	fT4, SSC SDS	p*	TSH, mU/L	p*
1–3	OT+	29	139	25.8 (0.7)	<0.001	2.16 (0.27)	<0.001	7.6 (2.2)	<0.001
	OT–	26	123	21.3 (0.6)		–0.59 (0.30)		21.7 (3.2)
3–6	OT+	18	59	27.6 (1.2)	<0.001	2.66 (0.43)	<0.001	3.1 (1.4)	0.012
	OT–	37	102	21.4 (0.7)		–0.10 (0.21)		9.1 (1.5)
6–24	OT+	26	249	22.9 (0.7)	0.003	0.44 (0.18)	<0.001	5.4 (1.0)	0.009
	OT–	29	290	20.1 (0.6)		–0.87 (0.22)		9.6 (1.2)
1–3	UT+	10	51	19.0 (1.5)	<0.001	–1.22 (0.73)	<0.001	24.4 (6.5)	<0.001
	UT–	45	211	25.1 (0.8)		1.53 (0.35)		10.7 (2.2)
3–6	UT+	10	35	19.0 (1.3)	<0.001	–0.77 (0.62)	<0.001	14.1 (4.5)	<0.001
	UT–	45	126	24.7 (0.9)		1.27 (0.37)		5.5 (1.3)
6–24	UT+	31	296	20.1 (0.6)	<0.001	–0.83 (0.20)	<0.001	8.9 (1.5)	<0.001
	UT–	24	243	22.6 (0.7)		0.53 (0.18)		4.6 (1.2)

fT ₄ and TSH concentration values are presented as mean (SEM).

^*Bold p values: significant difference between OT+/OT– and UT+/UT–groups.